Hydromer, Inc. (HYDI)
| Market Cap | 1.11M -24.5% |
| Revenue (ttm) | 5.63M -1.9% |
| Net Income | 60.91K |
| EPS | 0.01 |
| Shares Out | 6.51M |
| PE Ratio | 13.32 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,354 |
| Open | 0.1700 |
| Previous Close | 0.2200 |
| Day's Range | 0.1700 - 0.1700 |
| 52-Week Range | 0.0011 - 0.4500 |
| Beta | -0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Hydromer
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products. The company also provides cosmetics and personal care products, and watercraft hulls coating products; and engineering and contract coating services. It serves... [Read more]
News
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024
CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for o...
Hydromer, Inc. forms new Research and Development division
Hydromer announced the formation of a new Research and Development division. This restructuring introduces a science team focused on innovation and performance, adding two Ph.D. chemists and one M.S. ...
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development
Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions. Restructured R&D division, under new leadership,...
Hydromer, Inc. reports preliminary Q2 revenue $836,000 vs. $1.2M last year
The company said, “We believe that the decline in sales is attributed to attrition in our legacy customer base, lack of innovation, and insufficient sales prospecting efforts in the previous…
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update
CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over...
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024
CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for me...
Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations
CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer, Inc. (OTC: HYDI)
Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation
CONCORD, NC, Dec. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer, Inc (OTC: HYDI) is pleased to announce the Company rebranding initiatives (the “Initiatives”) reflecting the Company's conti...
Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel
CONCORD, NC, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer, Inc (OTC: HYDI), is thrilled to announce the formation of the Company's first Scientific Advisory Board and proudly introduc...
Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti
CONCORD, NC, Sept. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hydromer Inc. (OTC: HYDI) ("The Company"), a worldwide supplier of specialty coatings and biopolymers for medical devices and industr...
Hydromer Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara
Hydromer is returning to the medical device conference circuit in pursuit of partnerships and new customers CONCORD, NC, Aug. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hydromer Inc. (OTC: HYDI) ...
Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors
CONCORD, NC, Aug. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer, Inc. (OTC: HYDI) today announced the resignation of all its board of directors. There were no disagreements between the Comp...
Hydromer Inc. Shares Message from CEO Michael E. Torti
CONCORD, NC , July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hydromer Inc. (OTC: HYDI), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications...
Hydromer Inc Appoints New CEO
Concord, NC, April 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer Inc. (OTC: HYDI), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications...
Hydromer, Inc. Announces Removal of CEO
Hydromer Board of Directors Removes Peter von Dyck as CEO
Hydromer Inc. Announces the Addition of Michael Torti as Vice President of Sales, Marketing and Business Development
Concord, NC, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Mr. Michael Torti has vast experience in B2B sales and marketing of complex manufactured goods and medical devices and as of January 9th, 2023 has joined...
Hydromer Inc., Announces the Addition of Cam Cruickshank, Ph.D. to the Company's Board of Directors, Replacing the Retiring Mr.
Concord, NC, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hydromer, Inc. (the “Company”) (HYDI:OTC), a world-wide supplier of specialty coatings for medical devices and industrial applicati...
Hydromer Announces the Addition of Cortney Wells as the Company's New Director of Finance
Concord, NC, Nov. 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hydromer, Inc. (the “Company”) (HYDI:OTC), a world-wide supplier of specialty coatings for medical devices and industrial application...